Blis Technologies requests trading halt regarding patent
Fri, 20 Sep 2024
NZX-listed Blis Technologies has entered a trading halt. The probiotic manufacturer requested a trading halt after becoming aware of a patent filing that could potentially significantly affect the company. In a notice to NZ RegCo, the company said it needed time to assess those impacts, including
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).